Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
ScreenPoint Medical, The Breast AI Company, highlights new research from Sweden's Mammography Screening with Artificial Intelligence (MASAI) large-scale randomized controlled trial, which shows that ...
Telesurgery (operating on a patient remotely using a surgical robot via a secure telecommunication link) appears to be as ...
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for ...
The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...
Artificial intelligence helps doctors spot more cases of breast cancer when reading routine scans, a world-first trial found ...
The initiation of patient enrolment in the STARS DAPT trial marks an important milestone for Abluminus np. While contemporary ...
“Well, we don’t have as much evidence as we would like on steroid use during pregnancy,” the obstetrician warned my co-author, Natalia Emanuel, as she wrote a prescription for inhaled corticosteroids ...
Patients with radiologically staged T3-4, N0-2, M0 colon cancer were randomly allocated (2:1) to 6 weeks oxaliplatin-fluoropyrimidine preoperatively plus 18 postoperatively (NAC group) or 24 weeks ...
Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results